Feasibility of cancer immunotherapy with wt1 peptide vaccination for solid and hematological malignancies in children

Feasibility of cancer immunotherapy with wt1 peptide vaccination for solid and hematological malignancies in children

A Sawada, M Inoue, O Kondo… - Pediatric blood & …, 2016 - Wiley Online Library

... Peptide Company Inc. (San Diego, CA), NeoMPS Inc. (San Diego, CA), and Peptide
Institute Inc. (Ibaraki, Japan). Freund's incomplete adjuvant of Montanide ISA51
was purchased from Seppic Inc. (Paris, France). The WT1 ...

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com